We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 43.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+43.27%
3 Year Est. Return
+162.77%
5 Year Est. Return
+210.46%
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
-$97.4M
Cap. Flow
-$7.48M
Cap. Flow %
-0.37%
Top 10 Hldgs %
11.33%
Holding
698
New
210
Increased
118
Reduced
125
Closed
177

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$18.9M
2
BAX icon
Baxter International
BAX
+$18.2M
3
EXE
Expand Energy Corp
EXE
+$17M
4
TMUS icon
T-Mobile US
TMUS
+$16.5M
5
MRK icon
Merck
MRK
+$16.3M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$22.2M
2
PLAN
Anaplan, Inc.
PLAN
+$21M
3
PAYC icon
Paycom
PAYC
+$19.5M
4
CNQ icon
Canadian Natural Resources
CNQ
+$14.1M
5
GILD icon
Gilead Sciences
GILD
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.39%
2 Technology 17.9%
3 Consumer Discretionary 12.08%
4 Miscellaneous 10.97%
5 Financials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
1
CALL
Salesforce
CRM
$213B
$35.3M 1.73%
+130,000
New +$33M
CTRA
2
CALL
DELISTED
Coterra Energy
CTRA
$33.7M 1.65%
+1,550,000
New +$26.6M
ABBV icon
3
CALL
AbbVie
ABBV
$453B
$27M 1.32%
+250,000
New +$28.6M
UNH icon
4
UnitedHealth
UNH
$356B
$20.8M 1.02%
53,184
-14,529
-21% -$6.02M
AVTR icon
5
Avantor
AVTR
$10.1B
$20M 0.98%
489,587
-30,001
-6% -$1.17M
CRM icon
6
Salesforce
CRM
$213B
$19.8M 0.97%
73,107
-713
-1% -$181K
TMO icon
7
Thermo Fisher Scientific
TMO
$227B
$19.7M 0.96%
+34,421
New +$18.9M
EXE
8
Expand Energy Corp
EXE
$22.7B
$18.7M 0.92%
+303,802
New +$17M
BAX icon
9
Baxter International
BAX
$13.4B
$18.6M 0.91%
+230,853
New +$18.2M
AMD icon
10
CALL
Advanced Micro Devices
AMD
$780B
$18M 0.88%
+175,000
New +$17.9M
GM icon
11
General Motors
GM
$77B
$17M 0.83%
323,284
+162,403
+101% +$8.63M
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$16.6M 0.81%
151,235
+7,605
+5% +$789K
MRK icon
13
Merck
MRK
$371B
$16.1M 0.79%
+214,690
New +$16.3M
AMD icon
14
Advanced Micro Devices
AMD
$780B
$16.1M 0.79%
156,339
-24,637
-14% -$2.52M
TMUS icon
15
T-Mobile US
TMUS
$195B
$15.1M 0.74%
+118,201
New +$16.5M
MRK icon
16
CALL
Merck
MRK
$371B
$15M 0.74%
+200,000
New +$15.2M
PXD
17
DELISTED
Pioneer Natural Resource Co.
PXD
$14.9M 0.73%
+89,710
New +$13.6M
ABBV icon
18
AbbVie
ABBV
$453B
$14.6M 0.72%
135,427
-8,327
-6% -$951K
CTRA
19
DELISTED
Coterra Energy
CTRA
$14.5M 0.71%
666,719
+187,502
+39% +$3.22M
KAHC
20
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$14.4M 0.71%
1,479,579
– –
ZEN
21
DELISTED
ZENDESK INC
ZEN
$14.4M 0.7%
123,755
+47,107
+61% +$6.09M
VEI
22
DELISTED
Vine Energy Inc.
VEI
$14.2M 0.69%
860,594
+302,146
+54% +$4.53M
SES icon
23
SES AI
SES
$187M
$13.5M 0.66%
1,364,723
– –
NVST icon
24
Envista
NVST
$4.38B
$13.3M 0.65%
318,588
+233,153
+273% +$9.83M
BOAC
25
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$13.2M 0.65%
1,348,291
+614,004
+84% +$6.01M
1
2 3 4 5

Similar funds

ACP
Avantyr Capital Partners New York $2.72B AUM
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $2.72B AUM
SCM
Steele Capital Management Dubuque, Iowa $2.72B AUM 21.58% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 2.36% 1-Year Est. Return
GXJ
Global X Japan Chiyoda-Ku, Tokyo, Japan $2.72B AUM 45.88% 1-Year Est. Return
GC
Glenorchy Capital Boorolite, Australia $2.71B AUM 54.26% 1-Year Est. Return
NIM
Northeast Investment Management Boston, Massachusetts $2.71B AUM 25.45% 1-Year Est. Return
AG
Avala Global New York $2.71B AUM 130.04% 1-Year Est. Return

Cinctive Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Cinctive Capital Management held 698 positions worth $2.04B, down 4.6% from $2.14B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cinctive Capital Management's Q3 2021 filing shows 210 new, 118 increased, 125 reduced and 177 closed positions. Its largest new stake was Thermo Fisher Scientific: 34,421 shares worth $19.7M. The largest sale was Elevance Health, an estimated $22.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Cinctive Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 34,421 shares worth $19.7M.
  • Cinctive Capital Management added most to Eli Lilly in Q3 2021, an estimated $11.2M increase.
  • Cinctive Capital Management's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $22.2M.
  • Cinctive Capital Management fully exited Canadian Natural Resources in Q3 2021, selling an estimated $14.1M.
  • Cinctive Capital Management's ten largest holdings make up 11% of its $2.04B portfolio in Q3 2021.
  • Cinctive Capital Management opened 210 new positions and closed 177 in Q3 2021.
  • Cinctive Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.04B.

Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.